We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+5.65%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.01B
AUM Growth
+$205M
(+25%)
Cap. Flow
+$234M
Cap. Flow
% of AUM
23.15%
Top 10 Holdings %
Top 10 Hldgs %
4.25%
Holding
2,085
New
689
Increased
399
Reduced
339
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
National Vision
EYE
|
+$5.45M |
| 2 |
Altimmune
ALT
|
+$4.45M |
| 3 |
FRC
First Republic Bank
FRC
|
+$4.06M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.99M |
| 5 |
Hilton Worldwide
HLT
|
+$3.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$7.74M |
| 2 |
Dropbox
DBX
|
+$3.02M |
| 3 |
Progressive
PGR
|
+$2.77M |
| 4 |
Southwest Airlines
LUV
|
+$2.69M |
| 5 |
Transocean
RIG
|
+$2.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 14.87% |
| 3 | Healthcare | 14.13% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Invesco S&P 500 Top 50 ETF
XLG
$11B
| $264K | 0.03% |
+8,500
| New | +$249K |
|
|
EVBG
1102
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $264K | 0.03% |
+7,602
| New | +$243K |
|
1103
iShares MSCI Mexico ETF
EWW
$1.92B
| $263K | 0.03% |
+4,423
| New | +$252K |
|
1104
Huntsman Corp
HUN
$1.77B
| $263K | 0.03% |
+9,596
| New | +$286K |
|
1105
Titan Machinery
TITN
$445M
| $263K | 0.03% |
+8,646
| New | +$352K |
|
|
AVTA
1106
DELISTED
Avantax, Inc. Common Stock
AVTA
| $263K | 0.03% |
9,990
-44,219
| -82% | -$1.2M |
|
1107
Aclaris Therapeutics
ACRS
$869M
| $262K | 0.03% |
+32,358
| New | +$411K |
|
1108
Diamondrock Hospitality Co
DRH
$2.56B
| $262K | 0.03% |
32,250
-152,168
| -83% | -$1.32M |
|
1109
Bentley Systems
BSY
$10.6B
| $261K | 0.03% |
+6,065
| New | +$241K |
|
1110
Cue Biopharma
CUE
$114M
| $261K | 0.03% |
2,437
-3,840
| -61% | -$366K |
|
1111
Comscore
SCOR
$109M
| $261K | 0.03% |
10,604
+7,996
| +307% | +$194K |
|
|
OMIC
1112
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $261K | 0.03% |
7,190
+4,123
| +134% | +$253K |
|
|
CNR
1113
Core Natural Resources Inc
CNR
$4.45B
| $260K | 0.03% |
4,454
-2,679
| -38% | -$153K |
|
|
NEWR
1114
DELISTED
New Relic, Inc.
NEWR
| $260K | 0.03% |
3,447
-123
| -3% | -$8.31K |
|
1115
Altisource Portfolio Solutions
ASPS
$65.8M
| $259K | 0.03% |
+7,039
| New | +$340K |
|
1116
Vertex
VERX
$1.94B
| $259K | 0.03% |
+12,533
| New | +$193K |
|
|
AMRN
1117
Amarin Corp
AMRN
$303M
| $258K | 0.03% |
+8,596
| New | +$301K |
|
1118
Gilat Satellite Networks
GILT
$848M
| $257K | 0.03% |
50,186
+4,135
| +9% | +$23.5K |
|
1119
Kemper
KMPR
$1.68B
| $257K | 0.03% |
+4,696
| New | +$272K |
|
1120
First Trust Nasdaq Artificial Intelligence and Robotics ETF
ROBT
$774M
| $257K | 0.03% |
+6,036
| New | +$244K |
|
1121
Wingstop
WING
$3.18B
| $257K | 0.03% |
+1,399
| New | +$230K |
|
1122
BioMarin Pharmaceuticals
BMRN
$12.4B
| $256K | 0.03% |
2,635
-1,908
| -42% | -$198K |
|
1123
Chevron
CVX
$366B
| $256K | 0.03% |
+1,572
| New | +$264K |
|
1124
Kroger
KR
$34.8B
| $256K | 0.03% |
+5,177
| New | +$237K |
|
1125
Danaher
DHR
$144B
| $255K | 0.03% |
+1,139
| New | +$259K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2023 Portfolio in Review
As of Q1 2023, GSA Capital Partners held 2,085 positions worth $1.01B, up 25% from $806M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.
GSA Capital Partners deployed $234M of net new capital in Q1 2023, opening 689 new positions and adding to 399 existing holdings. Its largest new stake was National Vision: 167,499 shares worth $3.16M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Transocean, an estimated $2.59M trimmed.
- GSA Capital Partners's largest Q1 2023 buy was National Vision: 167,499 shares worth $3.16M.
- GSA Capital Partners added most to Altimmune in Q1 2023, an estimated $4.45M increase.
- GSA Capital Partners's biggest Q1 2023 reduction was Transocean, cutting an estimated $2.59M.
- GSA Capital Partners fully exited PG&E in Q1 2023, selling an estimated $7.74M.
- GSA Capital Partners's ten largest holdings make up 4.2% of its $1.01B portfolio in Q1 2023.
- GSA Capital Partners opened 689 new positions and closed 654 in Q1 2023.
- GSA Capital Partners's portfolio value rose 25% quarter-over-quarter to $1.01B.
Based on GSA Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.